Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIXC
3601
AIxCrypto Holdings Inc
AIXC
$14M
| $17K | ﹤0.01% |
+859
| New | +$20.1K |
|
3602
Rockwell Medical
RMTI
$30.9M
| $17K | ﹤0.01% |
1,051
-8,769
| -89% | -$127K |
|
|
AKLI
3603
DELISTED
Akili Inc
AKLI
| $17K | ﹤0.01% |
57,800
+35,500
| +159% | +$11.1K |
|
3604
Biofrontera
BFRI
$16.1M
| $16K | ﹤0.01% |
+10,221
| New | +$14.2K |
|
3605
Corvex Inc
MOVE
$308M
| $16K | ﹤0.01% |
361
-224
| -38% | -$15K |
|
3606
VerifyMe
VRME
$9.06M
| $16K | ﹤0.01% |
+11,700
| New | +$13.7K |
|
|
GLDG
3607
GoldMining Inc
GLDG
$226M
| $15K | ﹤0.01% |
17,500
-13,749
| -44% | -$11.5K |
|
3608
Moving iMage Technologies
MITQ
$5.56M
| $15K | ﹤0.01% |
32,000
-3,596
| -10% | -$2.67K |
|
|
NUTX
3609
Nutex Health
NUTX
$1.28B
| $15K | ﹤0.01% |
1,049
-2,096
| -67% | -$42.2K |
|
3610
TDH Holdings
PETZ
$15.5M
| $15K | ﹤0.01% |
+13,000
| New | +$14.9K |
|
|
DCOY
3611
Decoy Therapeutics
DCOY
$1.88M
| $15K | ﹤0.01% |
20
+2
| +11% | +$1.72K |
|
|
JXG
3612
JX Luxventure
JXG
$85.6M
| $15K | ﹤0.01% |
204
-11
| -5% | -$925 |
|
3613
Alzamend Neuro
ALZN
$7M
| $14K | ﹤0.01% |
153
+40
| +35% | +$3.43K |
|
3614
Bluejay Diagnostics
BJDX
$1.1M
| $14K | ﹤0.01% |
+11
| New | +$15.2K |
|
3615
Farmmi Inc
FAMI
$4.96M
| $14K | ﹤0.01% |
1,407
+25
| +2% | +$323 |
|
|
NXTP
3616
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
| $14K | ﹤0.01% |
20,749
+3,014
| +17% | +$3.74K |
|
|
IONM
3617
DELISTED
Assure Holdings Corp. Common Stock
IONM
| $14K | ﹤0.01% |
+1,606
| New | +$9.73K |
|
3618
CLPS Inc
CLPS
$26.1M
| $12K | ﹤0.01% |
11,332
+100
| +0.9% | +$102 |
|
3619
Kiora Pharmaceuticals
KPRX
$11.5M
| $12K | ﹤0.01% |
1,851
-227
| -11% | -$1.27K |
|
3620
SOBR Safe
SOBR
$1.67M
| $11K | ﹤0.01% |
+24
| New | +$14.3K |
|
|
SPI
3621
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
| $11K | ﹤0.01% |
18,200
-1,500
| -8% | -$963 |
|
|
EDBL
3622
Edible Garden
EDBL
$1.07M
| – | – |
0
| – | – |
|
3623
InMed Pharmaceuticals
INM
$7.64M
| $10K | ﹤0.01% |
1,415
-530
| -27% | -$3.9K |
|
3624
Upexi
UPXI
$54.8M
| $10K | ﹤0.01% |
840
+305
| +57% | +$5.56K |
|
|
WLGS
3625
DELISTED
Wang & Lee Group
WLGS
| $10K | ﹤0.01% |
+16,995
| New | +$11.6K |
|
Similar funds
Jim Simons's Q1 2024 Portfolio in Review
As of Q1 2024, Jim Simons held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Chevron worth $331M.
- Jim Simons's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Jim Simons added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Jim Simons's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Jim Simons fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Jim Simons's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Jim Simons opened 562 new positions and closed 582 in Q1 2024.
- Jim Simons's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.